Faculty

Institution

Unit

Venue

Harrys A. Torres

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Infectious Diseases

The University of Texas MD Anderson Cancer Center

NoneHarrys A. Torres is currently serving as a Infectious Diseases faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harrys A. Torres

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

hepatitis medicine viral hepatitis infectious diseases oncology hepatology medical virology pathology antiviral research hepatocellular carcinoma transplant infectious diseases epidemiology antiviral therapy liver cancer hematology infectious diseases (medical specialty) cancer research liver transplantation medical mycology viral oncology chronic viral infections virology cancer care virus research antiviral drugs infection control clinical mycology cancer immunotherapy hospital infections leukemia lymphoid neoplasia cancer patients bone marrow transplantation respiratory medicine thoracic oncology hematological malignancies cancer treatment transplantation medicine clinical microbiology surgical oncology antifungal agents clinical infection direct-acting antivirals hematologic malignancies ima fungus cancer management cancer-associated virus risk factors respiratory infections cancer risk diagnostic virology antiviral drug development immune checkpoint inhibitors prospective observational study second primary cancer clinical infectious disease medical microbiology diagnostic mycology fungal pathogens treatment and prevention human retrovirus infectious respiratory disease invasive aspergillosis hepatitis c cancer prevention neck oncology viral persistence clinical immunology haematologic malignancies non-fumigatus aspergillus species amphotericin b neck cancers solid tumors sofosbuvir-based therapy retrospective multicenter study treatment modalities

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-1827. Clinical Significance of Indeterminate Anti–Hepatitis C Antibody Test Results in Cancer Patients. Open Forum Infectious Diseases (2026)

hepatitisinfectious diseasesviral hepatitisinfectious diseases (medical specialty)medicinediagnostic testsmedical virologyserologic testingoncology

Direct‐Acting Antivirals Induce Lymphoproliferative Disease Response in Hcv‐Infected Patients With Indolent B‐Cell Non‐Hodgkin’s Lymphoma: A Prospective Observational Study. Hematological Oncology (2025)

hepatitispathologyinfectious diseasesvirologyviral hepatitischronic viral infectionsimmunologyhematologyantiviral researchantiviral therapyhcv‐infected patientsmedical virologylymphoid neoplasiaprospective observational study

Global Hepatitis C Elimination: Updates, Challenges, and Opportunities From Real-World Experiences in Europe and North America. Hepatology (2025)

hepatitistransplant infectious diseasesepidemiologyinfectious diseasesvaccinespreventive medicinevaccinationhepatologyglobal healthinfectious diseases (medical specialty)antiviral researchcommunicable diseasesinternational healthmedical virologycovid-19liver transplantationvirus eradication

Hepatitis E Virus Infection After Car T‐Cell Treatment: An Important Complication in Patients Already Facing Significant Health Challenges. British Journal of Haematology (2024)

Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. Journal of the National Comprehensive Cancer Network (2024)

hepatitisepidemiologypathologyinfectious diseasesviral hepatitishepatologyclinical laboratorytertiary cancer centerhepatocellular carcinoma

Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients With Cancer Receiving Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology (2024)

Severe Reactivation of Seronegative Occult Hepatitis B After Chemotherapy for Lymphoma. The Lancet (2024)

hepatitispathologyliver cancerhematologymedicinelymphoid neoplasiaoncologysevere reactivation

Viral Hepatitis B Reactivation With Delayed Cholestatic Effect Secondary to Acalabrutinib. ACG Case Reports Journal (2024)

hepatitisinfectious diseasesliver physiologyviral hepatitisliver diseasehepatologymedicinemedical virology

Virologic Effect and Hepatotoxicity of Bcr:: Abl1 Tyrosine Kinase Inhibitors in Cancer Patients With Chronic Hepatitis C Virus Infection: A Prospective Study. Leukemia Research (2024)

hepatitisliver cancerviral hepatitisliver physiologyprospective studyvirologic effecthepatologyantiviral drugsantiviral researchcancer researchantiviral therapymedicinepharmacologycancer patientshepatocellular carcinoma

Virologic Effect and Hepatotoxicity of Bcr:: Abl1 Tyrosine Kinase Inhibitors in Cancer Patients With Chronic Hepatitis C Virus Infection: A Prospective Study. Leukemia Research (2024)

hepatitisoncogenesviral hepatitishepatologyhematological malignanciescancer researchmedicinepharmacotherapyhepatocellular carcinomaleukemiaoncology

1
2
3
4
5
18
10 / page

Harrys A. Torres

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Infectious Diseases

The University of Texas MD Anderson Cancer Center

NoneHarrys A. Torres is currently serving as a Infectious Diseases faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harrys A. Torres

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-1827. Clinical Significance of Indeterminate Anti–Hepatitis C Antibody Test Results in Cancer Patients. Open Forum Infectious Diseases (2026)

hepatitisinfectious diseasesviral hepatitisinfectious diseases (medical specialty)medicinediagnostic testsmedical virologyserologic testingoncology

Global Hepatitis C Elimination: Updates, Challenges, and Opportunities From Real-World Experiences in Europe and North America. Hepatology (2025)

Hepatitis E Virus Infection After Car T‐Cell Treatment: An Important Complication in Patients Already Facing Significant Health Challenges. British Journal of Haematology (2024)

Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. Journal of the National Comprehensive Cancer Network (2024)

hepatitisepidemiologypathologyinfectious diseasesviral hepatitishepatologyclinical laboratorytertiary cancer centerhepatocellular carcinoma

Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients With Cancer Receiving Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology (2024)

Severe Reactivation of Seronegative Occult Hepatitis B After Chemotherapy for Lymphoma. The Lancet (2024)

hepatitispathologyliver cancerhematologymedicinelymphoid neoplasiaoncologysevere reactivation

Viral Hepatitis B Reactivation With Delayed Cholestatic Effect Secondary to Acalabrutinib. ACG Case Reports Journal (2024)

hepatitisinfectious diseasesliver physiologyviral hepatitisliver diseasehepatologymedicinemedical virology

Virologic Effect and Hepatotoxicity of Bcr:: Abl1 Tyrosine Kinase Inhibitors in Cancer Patients With Chronic Hepatitis C Virus Infection: A Prospective Study. Leukemia Research (2024)

hepatitisoncogenesviral hepatitishepatologyhematological malignanciescancer researchmedicinepharmacotherapyhepatocellular carcinomaleukemiaoncology

1
2
3
4
5
18
10 / page